CDI prevention reaches date with destiny

Clinical stage outfit, Destiny Pharma, provides a positive summary of the year ahead

Read on PharmaTimes

Poolbeg Pharma dives into nasally administered antivirals

If we have learnt anything from the last two years, it’s that virus protection is not to be sniffed at

Read on PharmaTimes

Gates Foundation supports HIV and malaria research

Vir Biotech has launched a new antibody research initiative, expanding its partnership with the Bill & Melinda Gates Foundation

Read on PharmaTimes

While Omicron continues to dominate across the world, COVID-19 travel requirements remain

Djokovic drama causes a racket: so how would the UK respond?

Read on PharmaTimes

New study finds AstraZeneca booster generates higher antibodies against Omicron

AstraZeneca (AZ) has reported preliminary data from a trial it conducted on its COVID-19 booster shot, Vaxzevria.

Read on PharmaTimes

1 2 3

Top of page

Industry News

Clinical stage outfit, Destiny Pharma, provides a positive summary of the year ahead.
Read More >

More Stories

News

Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >

More Stories

Latest Tweets

Follow Us